AU2003229293A1 - Cancer-linked gene as target for chemotherapy - Google Patents

Cancer-linked gene as target for chemotherapy

Info

Publication number: AU2003229293A1
Authority: AU; Australia
Prior art keywords: chemotherapy; cancer; target; linked gene; gene
Prior art date: 2002-05-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003229293A

Other versions

AU2003229293A8 (en

Inventor

Reinhard Ebner

Zoe Weaver

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Clinical Data Inc

Original Assignee

Avalon Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-16

Filing date

2003-05-15

Publication date

2003-12-02

2003-05-15 Application filed by Avalon Pharmaceuticals Inc filed Critical Avalon Pharmaceuticals Inc

2003-12-02 Publication of AU2003229293A1 publication Critical patent/AU2003229293A1/en

2003-12-02 Publication of AU2003229293A8 publication Critical patent/AU2003229293A8/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Cell Biology (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU2003229293A 2002-05-16 2003-05-15 Cancer-linked gene as target for chemotherapy Abandoned AU2003229293A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38091202P	2002-05-16	2002-05-16
US60/380,912		2002-05-16
PCT/US2003/015313 WO2003097802A2 (en)	2002-05-16	2003-05-15	Cancer-linked gene as target for chemotherapy

Publications (2)

Publication Number	Publication Date
AU2003229293A1 true AU2003229293A1 (en)	2003-12-02
AU2003229293A8 AU2003229293A8 (en)	2003-12-02

Family

ID=29550036

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003229293A Abandoned AU2003229293A1 (en)	2002-05-16	2003-05-15	Cancer-linked gene as target for chemotherapy

Country Status (4)

Country	Link
EP (1)	EP1513951A4 (en)
AU (1)	AU2003229293A1 (en)
CA (1)	CA2485981A1 (en)
WO (1)	WO2003097802A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2537859A1 (en)	2011-06-23	2012-12-26	Université de Mons	Molecules specifically binding pancreatic beta cells biomarkers
UA128472C2 (en)	2017-08-25	2024-07-24	Файв Прайм Терапеутікс Інк.	B7-H4 ANTIBODIES AND METHODS OF THEIR USE
BR112020016986A2 (en)	2018-02-21	2021-03-02	Five Prime Therapeutics, Inc.	antibody formulations against b7-h4
CA3091801A1 (en)	2018-03-02	2019-09-06	Five Prime Therapeutics, Inc.	B7-h4 antibodies and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1190051A2 (en) *	1999-06-17	2002-03-27	Incyte Genomics, Inc.	Human transport proteins
AU2001271284A1 (en) *	2000-06-07	2001-12-17	Corixa Corporation	Compositions and methods for the therapy and diagnosis of pancreatic cancer

2003
- 2003-05-15 AU AU2003229293A patent/AU2003229293A1/en not_active Abandoned
- 2003-05-15 EP EP03726880A patent/EP1513951A4/en not_active Withdrawn
- 2003-05-15 WO PCT/US2003/015313 patent/WO2003097802A2/en not_active Ceased
- 2003-05-15 CA CA002485981A patent/CA2485981A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2485981A1 (en)	2003-11-27
EP1513951A4 (en)	2005-12-28
WO2003097802A2 (en)	2003-11-27
WO2003097802A3 (en)	2004-12-29
EP1513951A2 (en)	2005-03-16
AU2003229293A8 (en)	2003-12-02

Similar Documents

Publication	Publication Date	Title
AU2003245441A1 (en)	2003-12-31	Cancer-linked gene as target for chemotherapy
AU2003229294A1 (en)	2003-12-02	Cancer-linked gene as target for chemotherapy
AU2003239969A1 (en)	2003-12-19	Cancer-linked gene as target for chemotherapy
EP1575492A3 (en)	2005-09-15	Cancer-linked gene as target for chemotherapy
AU2003249691A1 (en)	2003-12-22	Cancer-linked gene as target for chemotherapy
EP1576111A3 (en)	2005-09-01	Cancer-linked gene as target for chemotherapy
AU2003253677A1 (en)	2003-12-22	Cancer-linked gene as target for chemotherapy
AU2003213743A1 (en)	2003-09-22	Cancer-linked gene as target for chemotherapy
AU2003238897A1 (en)	2003-12-22	Cancer-linked gene as target for chemotherapy
AU2003229293A1 (en)	2003-12-02	Cancer-linked gene as target for chemotherapy
AU2003247564A1 (en)	2003-12-31	Cancer-linked gene as target for chemotherapy
WO2003075854A8 (en)	2006-05-18	Cancer-linked gene as target for chemotherapy
AU2003237414A1 (en)	2003-12-22	Cancer-linked gene as target for chemotherapy
AU2003218014A1 (en)	2003-09-22	Cancer-linked gene as target for chemotherapy
AU2003241456A1 (en)	2003-12-02	Cancer-linked gene as target for chemotherapy
AU2003243440A1 (en)	2003-12-22	Cancer-linked gene as target for chemotherapy
AU2003213672A1 (en)	2003-09-22	Cancer-linked gene as target for chemotherapy
AU2003248528A1 (en)	2003-12-02	Cancer-linked gene as target for chemotherapy
AU2003245536A1 (en)	2003-12-22	Cancer-linked gene as target for chemotherapy
AU2003240572A1 (en)	2003-12-19	Cancer-linked gene as target for chemotherapy
AU2003241455A1 (en)	2003-12-02	Cancer-linked gene as target for chemotherapy
AU2003276643A1 (en)	2003-12-31	Cancer-linked gene as target for chemotherapy
AU2003245448A1 (en)	2003-12-31	Cancer-linked gene as target for chemotherapy
AU2003251515A1 (en)	2003-12-22	Cancer-linked gene as target for chemotherapy

Legal Events

Date	Code	Title	Description
2005-02-03	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase